Loading...
Home Page 2017-10-09T09:50:25+00:00

The Future of Healthcare

Humans have spent centuries looking to create novel therapies to help extend and increase the well-being or our lives for the present and future generations. With the advancement in molecular and cell biology, the power of true healing is being revealed in our own cells.

Human Cell and Tissue Products

Research has shown that the use of human cell and tissue products from umbilical cord and other birth tissues could potentially have a disruptive affect on the way certain injuries and human ailments are treated.

Proprietary Processing

Predictive utilizes advanced tissue harvesting techniques to create the best minimally manipulated allograft tissue products.  Our tissue donor program performs extensive background checks and testing in order to ensure the quality of the donation.

Quality and Experience

Predicitive’s team of research scientist and technicians have decades of experience with the tissue processing and cell biology.  We are working tirelessly to convert the latest and greatest scientific discoveries into viable therapies for the masses.

Learn More

Predictive Biotech a Leading provider of novel allograft tissue products

Our flagship allograft CoreCyte™ is engineered to maintain the structural and cellular characteristics of Wharton's Jelly.
Learn More

Products

CoreCyte™ is a minimally manipulated human tissue allograft suspension derived from the Wharton’s Jelly of the umbilical cord. CoreCyte™ is processed to preserve the biological and structural integrity of Wharton’s jelly for homologous use.

PolyCyte™ is a minimally manipulated human tissue allograft suspension derived from the Wharton’s Jelly of the umbilical cord. PolyCyte™ is processed to preserve the molecular profiles of cytokines, growth factors and proteins in Wharton’s jelly for homologous use

AmnioCyte Plus™ is a minimally manipulated human tissue allograft suspension derived from the extracellular matrix of the amniotic membrane. AmnioCyte Plus™ is processed to preserve the cellular scaffolding proteins and cytokines in amniotic membrane for homologous use.

AmnioCyte™ is a minimally manipulated human tissue allograft derived from amniotic fluid. AmnioCyte™  is processed to preserve the molecular profiles of cytokines, growth factors and proteins in amniotic fluid for homologous use.

CoreCyte™, PolyCyte™, AmnioCyte Plus™ and AmnioCyte™ are processed from donated human tissue from full term deliveries and is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Follow us for updates and news!